Tocilizumab for the treatment of severe coronavirus disease 2019

…, TBH Ibrahim, SH Shaar, S Abdalla… - Journal of medical …, 2020 - Wiley Online Library
Tocilizumab, an interleukin‐6 inhibitor, may ameliorate the inflammatory manifestations
associated with severe coronavirus disease 2019 (COVID‐19) and thus improve clinical …

[HTML][HTML] The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study

…, MN Badawi, FB Abid, SH Abu Jarir, S Abdalla… - BMC infectious …, 2020 - Springer
Background There are limited data on Coronavirus Disease 2019 (COVID-19) outcomes at
a national level, and none after 60 days of follow up. The aim of this study was to describe …

[HTML][HTML] Fatal coronavirus disease 2019-associated pulmonary aspergillosis; a report of two cases and review of the literature

S Abdalla, MA Almaslamani, SM Hashim, AS Ibrahim… - IDCases, 2020 - Elsevier
Coronavirus Disease 2019 (COVID-19)-associated pulmonary aspergillosis is an emerging
entity. We report two fatal cases of putative COVID-19-associated pulmonary aspergillosis. …

[HTML][HTML] From Farm-to-Fork: E. Coli from an Intensive Pig Production System in South Africa Shows High Resistance to Critically Important Antibiotics for Human and …

SE Abdalla, ALK Abia, DG Amoako, K Perrett… - Antibiotics, 2021 - mdpi.com
Antibiotic resistance profiles of Escherichia coli were investigated in an intensive pig production
system in the uMgungundlovu District, South Africa, using the ‘farm-to-fork’ approach. …

Food animals as reservoirs and potential sources of multidrug-resistant diarrheagenic E. coli pathotypes: Focus on intensive pig farming in South Africa

SE Abdalla, ALK Abia, DG Amoako… - … Journal of Veterinary …, 2022 - journals.co.za
Background Diarrheagenic E. coli (DEC) strains are a major cause of diarrheal diseases in
both developed and developing countries. Healthy asymptomatic animals may be reservoirs …

[HTML][HTML] Favipiravir for the treatment of coronavirus disease 2019 pneumonia; a propensity score-matched cohort study

RA Alattar, S Abdalla, T Abdallah, R Kazman… - Journal of Infection and …, 2022 - Elsevier
We retrospectively investigated the clinical outcomes of favipiravir in patients with COVID-19
pneumonia. Patients who between 23 May 2020 and 18 July 2020 received ≥ 24 h of …

Dilemma of Tocilizumab therapy for a patient with critical COVID‐19 disease and neutropenia: Case report and review of the literature

A Al Bishawi, S Abdalla, M Askar, W Kanjo… - Clinical Case …, 2022 - Wiley Online Library
Infection following SARS‐Co V‐2 leading to COVID‐19 disease is associated with significant
morbidity and mortality. The clinical entity, COVID‐19 cytokine storm syndrome (CSS) is a …

Favipiravir for the Treatment of Coronavirus Disease 2019; a propensity score-matched cohort study

RA Alattar, S Abdalla, TAK Abdallah, R Kazman… - medRxiv, 2021 - medrxiv.org
Background We investigated clinical outcomes of favipiravir in patients with COVID-19
pneumonia. Methods Patients who between 23 May 2020 and 18 July 2020 received ≥24 hours …

[HTML][HTML] Acute kidney injury caused by darunavir in a patient with COVID-19: A case report

S Abdalla, L Elgassim, F Rustom, M Othman - 2020 - europepmc.org
Background: A highly contagious virus known as SARS-CoV-2 has been a pandemic globally.
HIV medications were one of the suggested treatments for COVID-19. Here, we report an …

Enhancing student learning: Using design-based learning in a bridging program to improve critical thinking skills

M Ayub, A Al Sharawi, S Abdalla, N Ulumuddin… - Qscience …, 2014 - qscience.com
Bridging programs have been shown to be valuable because they allow students access to
higher education and lay a solid foundation by equipping them with the knowledge and skills …